Well, the Appendic 3C indicates they will burn through $6.888m in the March Quarter - most of it on R&D ($5.677m).
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025